Skip to main content
. 2022 Apr 28;13:871660. doi: 10.3389/fendo.2022.871660

Table 5.

Clinical characteristics of patients with ΔCPR of 1.0 ng/mL or higher.

Parameter All subjects (n = 39) Withdrawal group (n = 27) Non-withdrawal group (n = 12) p value
Male/female 19/20 14/13 5/7
Age (years) 63.2 ± 15.3 60.2 ± 16.3 70.1 ± 9.6 n.s
Duration of diabetes (years) 14.3 ± 11.3 11.1 ± 10.0 21.5 ± 10.9 <0.05
Body weight (kg) 69.4 ± 19.4 69.3 ± 19.0 69.5 ± 20.1 n.s
BMI (kg/m2) 27.1 ± 7.4 25.7 ± 4.7 30.1 ± 10.6 n.s
Grip strength (kg) 22.2 ± 10.8 23.8 ± 11.3 17.7 ± 7.7 n.s
Waist circumference (cm) 94.1 ± 17.8 91.0 ± 14.0 101.0 ± 22.7 n.s
Neck circumference (cm) 37.4 ± 3.9 37.7 ± 3.9 36.6 ± 3.8 n.s
Lower leg circumference (cm) 35.5 ± 4.6 36.1 ± 4.8 34.2 ± 3.8 n.s
Blood glucose on admission (mg/dL) 189.9 ± 85.4 186.7 ± 95.4 197.3 ± 56.0 n.s
HbA1c (%, NGSP) 11.5 ± 2.7 11.2 ± 2.6 12.1 ± 3.0 n.s
Glycoalbumin (%) 32.9 ± 10.5 31.2 ± 9.2 37.2 ± 12.3 n.s
AST (U/L) 21.2 ± 7.5 22.1 ± 8.1 19.1 ± 5.2 n.s
ALT (U/L) 25.2 ± 14.7 26.9 ± 16.2 22.3 ± 9.4 n.s
Creatinine (mg/dL) 0.79 ± 0.36 0.83 ± 0.39 0.72 ± 0.28 n.s
BUN (mg/dL) 18.8 ± 12.3 18.4 ± 14.3 19.8 ± 5.6 n.s
Total cholesterol (mg/dL) 202.1 ± 47.9 200.6 ± 46.3 205.5 ± 51.0 n.s
Triglyceride (mg/dL) 140.3 ± 88.6 143.6 ± 100.6 132.8 ± 51.7 n.s
LDL-cholesterol (mg/dL) 123.8 ± 40.5 125.2 ± 42.6 120.8 ± 35.1 n.s
HDL-cholesterol (mg/dL) 48.7 ± 12.2 46.3 ± 11.8 53.9 ± 11.2 n.s

Data presented as mean ± standard deviation. BMI, Body mass index; LDL-cholesterol, Low-density lipoprotein cholesterol; HDL-cholesterol, High-density lipoprotein cholesterol.

NS, Not Significant.